Mingjing Chen

Ms. Mingjing Chen

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2023 in Hypertension
Verified
Journal Article
Closed access
MCMingjing Chen
Mingjing Chen
GMGuanhong Miao
Guanhong Miao
YZYing Zhang
Ying Zhang
JUJason Gari Umans
Jason Gari Umans
ELElisa T. Lee
Elisa T. Lee
JZJinying Zhao
Jinying Zhao
BACKGROUND: Dyslipidemia is an important risk factor for hypertension and cardiovascular disease. Standard lipid panel cannot reflect the complexity of blood lipidome. The associations of individual lipid species with hypertension remain to be determined in large-scale epidemiological studies, especially in a longitudinal setting. METHODS: Using liquid chromatography-mass spectrometry, we repeatedly measured 1542 lipid species in 3699 fasting plasma samples at 2 visits (1905 at baseline, 1794 at follow-up, ~5.5 years apart) from 1905 unique American Indians in the Strong Heart Family Study. We first identified baseline lipids associated with prevalent and incident hypertension, followed by replication of top hits in Europeans. We then conducted repeated measurement analysis to examine the associations of changes in lipid species with changes in systolic blood pressure, diastolic blood pressure, and mean arterial pressure. Network analysis was performed to identify lipid networks associated with the risk of hypertension. RESULTS: Baseline levels of multiple lipid species, for example, glycerophospholipids, cholesterol esters, sphingomyelins, glycerolipids, and fatty acids, were significantly associated with both prevalent and incident hypertension in American Indians. Some lipids were confirmed in Europeans. Longitudinal changes in multiple lipid species, for example, acylcarnitines, phosphatidylcholines, fatty acids, and triacylglycerols, were significantly associated with changes in blood pressure measurements. Network analysis identified distinct lipidomic patterns associated with the risk of hypertension. CONCLUSIONS: Baseline plasma lipid species and their longitudinal changes are significantly associated with hypertension development in American Indians. Our findings shed light on the role of dyslipidemia in hypertension and may offer potential opportunities for risk stratification and early prediction of hypertension.

3 May 2024 in BMC Medical Education
Verified
Journal Article
Open access
PDF file
KDKewen Ding
Kewen Ding
MCMingjing Chen
Mingjing Chen
PLPing Li
Ping Li
ZXZichuan Xie
Zichuan Xie
HZHaorong Zhang
Haorong Zhang
HSHaibo Song
Haibo Song
Background: Effective teaching methods are needed to improve students’ abilities in hand-eye coordination and understanding of cardiac anatomy in echocardiography education. Simulation devices have emerged as innovative teaching tools and exhibited distinctive advantages due to their ability to provide vivid and visual learning experiences. This study aimed to investigate the effect of simulation of sectional human anatomy using ultrasound on students’ learning outcomes and satisfaction in echocardiography education. Methods: The study included 18 first-year clinical medical students with no prior echocardiography training. After randomization, they underwent a pre-test to assess basic knowledge. Following this, the students were divided into two groups: traditional teaching (traditional group) and simulation of sectional human anatomy using ultrasound (digital group). Each group received 60 min of instruction. Post-tests were assigned to students at two different time points: immediately after the lecture, and one week later (referred to as post-tests 1, and 2). In addition, anonymous questionnaires were distributed to students after class to investigate their satisfaction with teaching. Results: Both groups showed significant improvement in their scores on post-test 1 compared to pre-test (traditional group: from 33.1 ± 8.8 to 48.1 ± 13.1, P = 0.034 vs. digital group: from 35.0 ± 6.7 to 58.0 ± 13.2, P = 0.008). However, there were no significant differences between the two groups in several post-test comparisons. Student satisfaction ratings revealed that the digital group experienced significantly greater satisfaction in areas such as subject interest, teaching style, course alignment, and interaction compared to the traditional group. Additionally, 80% of the digital group strongly endorsed the use of simulation of sectional human anatomy using ultrasound for echocardiography teaching, highlighting its effectiveness. Conclusions: Simulation of sectional human anatomy using ultrasound may improve students’ understanding of echocardiography and satisfaction with the course. Our study provides evidence supporting the use of simulation teaching devices in medical education. Further research is needed to explore the long-term impact of this teaching method on students’ learning outcomes and its integration into the medical curriculum. Trial registration: http://www.chictr.org.cn (registration number: ChiCTR2300074015, 27/07/2023).

15 October 2024 in JCI Insight
Verified
Journal Article
Open access
PDF file
MCMingjing Chen
Mingjing Chen
ZHZhijie Huang
Zhijie Huang
GMGuanhong Miao
Guanhong Miao
JRJin Ren
Jin Ren
JLJinling Liu
Jinling Liu
JZJinying Zhao
Jinying Zhao
BACKGROUND: Left ventricular hypertrophy (LVH) and dyslipidemia are strong, independent predictors for cardiovascular disease, but their relationship is less well studied. A longitudinal lipidomic profiling of left ventricular mass (LVM) and LVH is still lacking. METHODS: Using liquid chromatography–mass spectrometry (LC-MS), we repeatedly measured 1,542 lipids from 1,755 unique American Indians attending 2 exams (mean, 5 years apart). Cross-sectional associations of individual lipid species with LVM index (LVMI) were examined by generalized estimating equation (GEE), followed by replication in an independent biracial cohort (65% White, 35% Black). Baseline plasma lipids associated with LVH risk beyond traditional risk factors were identified by logistic GEE model in American Indians. Longitudinal associations between changes in lipids and changes in LVMI were examined by GEE, adjusting for baseline lipids, baseline LVMI, and covariates. RESULTS: Multiple lipid species were significantly associated with LVMI or the risk of LVH in American Indians. Some lipids were confirmed in Black and White individuals. Moreover, some LVH-related lipids were inversely associated with risk of coronary heart disease (CHD). Longitudinal changes in several lipid species were significantly associated with changes in LVMI. CONCLUSION: Altered fasting plasma lipidome and its longitudinal change over time were significantly associated with LVMI and risk for LVH in American Indians. Our results offer insight into the role of individual lipid species in LV remodeling and risk of LVH, independent of known risk factors. FUNDING: This study was supported by the NIH grant (R01DK107532). The Strong Heart Study has been funded in whole or in part with federal funds from the National Heart, Lung, and Blood Institute, NIH, Department of Health and Human Services, under contract nos. 75N92019D00027, 75N92019D00028, 75N92019D00029, and 75N92019D00030.

10 February 2024 in Metabolites
Verified
Journal Article
Open access
PDF file
MCMingjing Chen
Mingjing Chen
GMGuanhong Miao
Guanhong Miao
ZHZhiguang Huo
Zhiguang Huo
Hao PengHao Peng
Hao Peng
XWXiaoxiao Wen
Xiaoxiao Wen
JZJinying Zhao
Jinying Zhao
It is well recognized that patients with severe obesity exhibit remarkable heterogeneity in response to different types of weight-loss interventions. Those who undergo Roux-en-Y gastric bypass (RYGB) usually exhibit more favorable glycemic outcomes than those who receive adjustable gastric banding (BAND) or intensive medical intervention (IMI). The molecular mechanisms behind these observations, however, remain largely unknown. To identify the plasma metabolites associated with differential glycemic outcomes induced by weight-loss intervention, we studied 75 patients with severe obesity (25 each in RYGB, BAND, or IMI). Using untargeted metabolomics, we repeatedly measured 364 metabolites in plasma samples at baseline and 1-year after intervention. Linear regression was used to examine whether baseline metabolites or changes in metabolites are associated with differential glycemic outcomes in response to different types of weight-loss intervention, adjusting for sex, baseline age, and BMI as well as weight loss. Network analyses were performed to identify differential metabolic pathways involved in the observed associations. After correction for multiple testing (q < 0.05), 33 (RYGB vs. IMI) and 28 (RYGB vs. BAND) baseline metabolites were associated with changes in fasting plasma glucose (FPG) or glycated hemoglobin (HbA1c). Longitudinal changes in 38 (RYGB vs. IMI) and 38 metabolites (RYGB vs. BAND) were significantly associated with changes in FPG or HbA1c. The identified metabolites are enriched in pathways involved in the biosynthesis of aminoacyl-tRNA and branched-chain amino acids. Weight-loss intervention evokes extensive changes in plasma metabolites, and the altered metabolome may underlie the differential glycemic outcomes in response to different types of weight-loss intervention, independent of weight loss itself.

26 May 2026 in medRxiv
Verified
Preprint
Open access
PDF file
MCMingjing Chen
Mingjing Chen
RNRose Noroozi
Rose Noroozi
MSMatthew D. Smith
Matthew D. Smith
MSMuraleetharan Sanjayan
Muraleetharan Sanjayan
CTCesar Higgins Tejera
Cesar Higgins Tejera
KFKathryn Fitzgerald
Kathryn Fitzgerald
Summary: Background: Progressive multiple sclerosis (MS) is characterized by ongoing neurodegeneration and limited therapeutic options. Circulating metabolites provide insight into disease biology, yet biomarkers that predict disability progression and reflect treatment response are lacking. We aimed to identify metabolomic signatures associated with longitudinal MRI measures of brain atrophy and to evaluate whether ibudilast treatment was associated with metabolite trajectories over time. Methods: We repeatedly profiled 1,726 plasma metabolites using untargeted UPLC-MS/MS in 244 participants (mean age 55.6 years; 53.3% female; 3.3% non-White) from the 96-week SPRINT-MS randomized trial of oral ibudilast (≤100 mg daily; n=123) versus placebo (n=121). Weighted gene co-expression network analysis was used to derive groups of related metabolites. Associations between baseline metabolites groups and longitudinal MRI outcomes were evaluated using linear mixed-effects models adjusted for demographic, clinical, and treatment covariates. The primary outcome was the rate of whole-brain atrophy measured by brain parenchymal fraction (BPF), defined as the proportion of intracranial volume occupied by brain tissue. Secondary outcomes included white matter fraction (WMF), gray matter fraction (GMF), and cortical thickness (CTH). Metabolite groups nominally associated with MRI outcomes (p<0.05) were followed by individual metabolite analyses to identify potential drivers. Significant metabolites were tested for replication in a comparable real-world observational HEAL-MS cohort with longitudinal MRI data (n=249; mean age 56.3 years; 71.1% female; 19.4% non-White). Lastly, we tested whether ibudilast treatment was associated with metabolite trajectories and performed metabolite set enrichment analysis. Findings: Higher baseline levels of glycerophospholipids were associated with slower decline in both BPF and WMF, and sphingomyelins were similarly associated with slower BPF decline. For example, higher 1-palmityl-2-stearoyl-GPC (O-16:0/18:0) levels were associated with slower BPF decline in SPRINT-MS (β=0.016 [0.008, 0.024]; p=4.35×10⁻ 5 ) and replicated in HEAL-MS (β=0.108 [0.006, 0.211], p=3.90×10⁻ 2 ). Metabolites associated with GMF preservation were enriched in androgenic steroids and steroid sulfates, with consistent positive associations observed in the replication cohort, whereas metabolites inversely associated with CTH were predominantly xenobiotic-related. Ibudilast treatment was associated with increased sphingomyelin species (e.g., palmitoyl sphingomyelin (d18:1/16:0); β = 0.185 [0.085, 0.286], FDR = 1.79×10 −2 ) and decreased levels of amino acid-related metabolites (e.g., anthranilate; β = –0.270 [–0.403, –0.137]; FDR = 3.87×10 −2 ). Pathway-based analyses corroborated these findings, highlighting glycerophospholipid and sphingolipid metabolism as key pathways implicated in brain atrophy in MS. Interpretation: Distinct lipid subsets were associated with slower brain atrophy in people with MS, and ibudilast treatment was associated with metabolite alterations in potentially neuroprotective directions. Metabolomics may provide prognostic and pharmacodynamic biomarkers for progressive MS. Funding: The study was supported by the National Institute of Neurological Disorders and Stroke (NINDS) grant R01NS133005 and the National Institute of Nursing Research (NINR) grants R01NR018851. Research in context: Evidence before this study: Circulating metabolites are altered in people with multiple sclerosis (MS). Before conducting this work, we systematically searched PubMed from database inception to March 23, 2026, for articles published in English using the search terms (“metabolomics” OR “plasma metabolites”) AND (“multiple sclerosis” OR “MS”) AND (“MRI” OR “brain atrophy” OR “brain parenchymal fraction” OR “gray matter” OR “white matter”) AND (“longitudinal” OR “progression” OR “brain atrophy”). We also reviewed reference lists of relevant publications. Prior studies have linked selected metabolites to clinical disability and brain atrophy in MS. However, most studies have been cross-sectional, limited by small sample sizes, or focused on case-control comparisons. Importantly, few studies have evaluated longitudinal associations between circulating metabolites and MRI-derived measures of brain atrophy, and studies integrating clinical trial data, external replication, and treatment-related metabolic changes remain scarce. Added value of this study: In a multicenter randomized clinical trial with longitudinal metabolomic profiling and MRI outcomes, we identified lipid-related metabolic signatures associated with brain atrophy, with consistent directionality observed in an independent cohort. We further demonstrated that ibudilast treatment was associated with longitudinal changes in specific metabolites, linking metabolic pathways to both disease progression and therapeutic response. Implications of all the available evidence: These findings support circulating metabolomic signatures as potential markers of brain atrophy in MS. Metabolomics may provide a scalable approach to identify individuals at risk of progressive brain tissue loss and to inform future mechanistic and therapeutic investigations targeting metabolic pathways involved in disability progression.

1 December 2025 in Journal of Cardiothoracic Surgery
Verified
Journal Article
Open access
PDF file
JDJingdan Deng
Jingdan Deng
MCMingjing Chen
Mingjing Chen
ZXZhenghua Xiao
Zhenghua Xiao
HSHaibo Song
Haibo Song
Complete avulsion accompanied by aortic root pseudoaneurysm is a rare complication of infective endocarditis (IE). Transesophageal echocardiography (TEE) p